Q4 2024 · 13F-HR
Mirabaud Asset Management (France) SASholdings as filed
Filed 2025-02-13 · accession 0002033031-25-000001
The Brief · Mirabaud Asset Management (France) SAS · Q4 2024
AI · grounded in 13F
Mirabaud Asset Management (France) SAS established a new position in LI AUTO INC [[stock:LI 0.25 05/01/28]] valued at $16.7M. The fund also initiated new holdings in EQUINOX GOLD CORP [[stock:EQXCN 4.75 10/15/28]] for $16.4M and RAPID7 INC [[stock:RPD 1.25 03/15/29]] for $11.7M. Additional new positions include HALOZYME THERAPEUTICS INC [[stock:HALO 1 08/15/28]], SEAGATE HDD CAYMAN [[stock:STX 3.5 06/01/28]], and AKAMAI TECHNOLOGIES INC [[stock:AKAM 0.125 05/01/25]].
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 50202MAB8 | LI 0.25 05/01/28 | LI AUTO INC | $16.7M | 19.5% | 14,450,000 | Common | SOLE |
| 29446YAC0 | EQXCN 4.75 10/15/28 | EQUINOX GOLD CORP | $16.4M | 19.0% | 14,820,000 | Common | SOLE |
| 753422AH7 | RPD 1.25 03/15/29 | RAPID7 INC | $11.7M | 13.5% | 12,100,000 | Common | SOLE |
| 40637HAF6 | HALO 1 08/15/28 | HALOZYME THERAPEUTICS INC | $8.6M | 10.0% | 7,950,000 | Common | SOLE |
| 81180WBL4 | STX 3.5 06/01/28 | SEAGATE HDD CAYMAN | $8.1M | 9.45% | 6,700,000 | Common | SOLE |
| 00971TAJ0 | AKAM 0.125 05/01/25 | AKAMAI TECHNOLOGIES INC | $8.0M | 9.28% | 7,500,000 | Common | SOLE |
| 02043QAB3 | ALNY 1 09/15/27 | ALNYLAM PHARMACEUTICALS INC | $5.6M | 6.47% | 5,200,000 | Common | SOLE |
| 94419LAP6 | W 3.25 09/15/27 | WAYFAIR INC | $5.5M | 6.40% | 5,100,000 | Common | SOLE |
| 23282WAC4 | CYTK 3.5 07/01/27 | CYTOKINETICS INC | $5.5M | 6.38% | 4,500,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.